Disc Medicine Target Price

See Disc Medicine's analyst price targets ($85) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$79.23

Average Target Price

$85.00

7.3% upside

3 analysts in the last 4 months

High: $90 | Low: $80

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-17	Morgan Stanley	$90	13.6% upside
2026-06-15	Morgan Stanley	$85	7.3% upside
2026-05-14	Morgan Stanley	$80	1% upside
2026-02-17	Wedbush	$88	11.1% upside
2026-02-17	Cantor FitzgeraldKristen Kluska	$125	57.8% upside
2026-02-17	Morgan Stanley	$75	5.3% downside
2026-02-17	Stifel Nicolaus	$110	38.8% upside
2026-02-17	BMO CapitalEvan Seigerman	$100	26.2% upside
2026-01-08	Morgan Stanley	$120	51.5% upside
2025-12-08	Raymond JamesMartin Auster	$117	47.7% upside
2025-11-10	Truist Financial	$114	43.9% upside
2025-10-17	National Bank	$153	93.1% upside
2025-10-17	Raymond James	$108	36.3% upside
2025-10-17	WedbushDavid Nierengarten	$110	38.8% upside
2024-11-05	ScotiabankGreg Harrison	$70	11.6% downside
2024-11-05	BMO CapitalEvan David Seigerman	$112	41.4% upside
2024-10-23	JefferiesRoger Song	$89	12.3% upside
2024-09-16	H.C. WainwrightDouglas Tsao	$70	11.6% downside
2024-08-22	Wells FargoTiago Fauth	$75	5.3% downside
2024-08-08	Raymond JamesDanielle Brill	$50	36.9% downside
2024-06-17	BMO CapitalEvan David Seigerman	$70	11.6% downside
2024-05-10	Raymond JamesDanielle Brill	$43	45.7% downside
2024-04-02	BMO CapitalEvan David Seigerman	$50	36.9% downside
2024-04-01	Stifel NicolausBen Burnett	$71	10.4% downside
2024-04-01	WedbushDavid Nierengarten	$43	45.7% downside
2024-04-01	Raymond JamesDanielle Brill	$40	49.5% downside

Disc Medicine (IRON) FAQ

Disc Medicine posts a target price of $85. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $85 for IRON means covering analysts, on average, see the stock 7.3% upside of $79.23 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for IRON's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Disc Medicine's other metric pages and overview cover the third.

Judging Disc Medicine against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $85 here, then scan peer and history charts to see if the gap is persistent.